These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 14049774)

  • 41. Drug-drug interactions and metabolism in cytochrome P450 2C knockout mice: application to troleandomycin and midazolam.
    Grimsley A; Gallagher R; Hutchison M; Pickup K; Wilson ID; Samuelsson K
    Biochem Pharmacol; 2013 Aug; 86(4):529-38. PubMed ID: 23732297
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experiences with triacetyloleandomycin in a rheumatic fever prophylaxis clinic.
    MOU TW
    Antibiot Annu; 1959-1960; 7():904-7. PubMed ID: 14424692
    [No Abstract]   [Full Text] [Related]  

  • 43. Hepatic dysfunction associated with triacetyloleandomycin demonstrated by "challenge".
    ROBINSON MM
    Am J Med Sci; 1962 Aug; 244():221-4. PubMed ID: 14492927
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of triacetyloleandomycin on bacterial infections of the respiratory tract.
    WAREMBOURG H
    Antibiot Annu; 1959-1960; 7():816-8. PubMed ID: 13842895
    [No Abstract]   [Full Text] [Related]  

  • 45. [TRIACETYLOLEANDOMYCIN. TREATMENT OF CUTANEOUS INFECTIONS IN CHILDREN. (APROPOS OF 42 CASES)].
    CORCOS V
    Clinique (Paris); 1964 Jan; 59():61-6. PubMed ID: 14132244
    [No Abstract]   [Full Text] [Related]  

  • 46. Method of dissolving triacetyloleandomycin for the assay of sensitivity of micro-organisms.
    CZEKALOWSKI JW
    Nature; 1961 Mar; 189():752-3. PubMed ID: 13719066
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinical and laboratory evaluation of evramycin (triacetyloleandomycin) in a variety of pyogenic infections].
    ISENBERG H; KARELITZ S; KLEMES R
    Rev Med Cubana; 1959 Jul; 70():336-9. PubMed ID: 14405885
    [No Abstract]   [Full Text] [Related]  

  • 48. [Antibiotic penetration into the otorhinolaryngologic system in children. I. Comparative intratonsillar penetration of ampicillin and triacetyloleandomycin. Apropos of 61 cases].
    Bégué P; Safran C; Quiniou F; Fifils A; Bodard M; Cotin G
    Ann Otolaryngol Chir Cervicofac; 1983; 100(4):239-41. PubMed ID: 6603811
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Falsely elevated values for urinary 17-ketosteroids and 17-hydroxycorticoids associated with ingestion of triacetyloleandomycin.
    NUMEROFF M; PERLMUTTER M; SLATER S
    J Clin Endocrinol Metab; 1959 Oct; 19():1350-2. PubMed ID: 14427898
    [No Abstract]   [Full Text] [Related]  

  • 50. [Intraocular penetration of triacetyloleandomycin].
    Bec P; Lareng B; Arne JL; Lemozy F; Mathis A
    Bull Soc Ophtalmol Fr; 1978; 78(6-7):479-81. PubMed ID: 312152
    [No Abstract]   [Full Text] [Related]  

  • 51. [Blood concentrations of oleandomycin after administration of triacetyloleandomycin].
    Caliò R; Pezzi R; Renzini G
    Gazz Int Med Chir; 1964 Dec; 68(24):Suppl:2540-7. PubMed ID: 5294274
    [No Abstract]   [Full Text] [Related]  

  • 52. [Benign drug jaundice during treatment combining rifampicin and triacetyloleandomycin].
    Piette F; Peyrard P
    Nouv Presse Med; 1979 Jan; 8(5):368. PubMed ID: 317969
    [No Abstract]   [Full Text] [Related]  

  • 53. [Triacetyloleandomycin-induced toxic hepatitis].
    Shishido H; Furusawa S; Amakawa T; Yamaguchi Y; Nakagawa M
    Naika; 1965 Nov; 16(6):1176-8. PubMed ID: 5296328
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmacokinetic interactions of the macrolide antibiotics.
    Ludden TM
    Clin Pharmacokinet; 1985; 10(1):63-79. PubMed ID: 3882305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [ON SEVERAL CASES OF SUCCESSFUL TREATMENT OF LUNG ABSCESS].
    MORII T; ADACHI H
    Iryo; 1964 Jan; 18():44-9. PubMed ID: 14126222
    [No Abstract]   [Full Text] [Related]  

  • 56. [Problems of hepatotoxocity of triacetyloleandomycin].
    Genazzani E; Di Carlo F; Caramia FG
    Med Chir Dig; 1976 May; 5(6):369-71. PubMed ID: 1087685
    [No Abstract]   [Full Text] [Related]  

  • 57. [A case of cholestatic jaundice due to tetracycline-triacetyloleandomycin].
    Ichida F; Watanabe K; Ishiwara S; Inoue K; Tanabe Y
    Nihon Naika Gakkai Zasshi; 1965 May; 54(2):142-7. PubMed ID: 5294320
    [No Abstract]   [Full Text] [Related]  

  • 58. Precipitation of acute ergotism by triacetyloleandomycin.
    Hayton AC
    N Z Med J; 1969 Jan; 69(440):42. PubMed ID: 5304704
    [No Abstract]   [Full Text] [Related]  

  • 59. [Study of triacetyloleandomycin in rheumatoid polyarthritis].
    Dreiser R; Kahn MF; de Seze S
    Therapeutique; 1972 Dec; 48(10):681-3. PubMed ID: 4574733
    [No Abstract]   [Full Text] [Related]  

  • 60. [Acute ergotism caused by dihydroergotamine-triacetyloleandomycin association].
    Franco A; Bourlard P; Massot C; Lecoeur J; Guidicelli H; Bessard G
    Nouv Presse Med; 1978 Jan; 7(3):205. PubMed ID: 307229
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.